Monopar Therapeutics Inc. (MNPR) has seen some recent movement in the marketplace and its common shares finished trading at $5.49 yesterday. Traders are starting to take notice of MNPR as the common shares traded as high as $5.59 and as low as $5.33 in the last market trading day.

Monopar Therapeutics Inc. (MNPR) average trading volume is 173.45K. However, in the last market trading day Monopar Therapeutics Inc. (MNPR) traded 53,213 shares. First upside resistance level on MNPR is $14.42. MNPR 50-day moving average is $6.46 and MNPR 200-day moving average is $7.48.

Monopar Therapeutics Inc. (MNPR) most recent performance has been indicated by the recent movement in MNPR common shares. MNPR has performed -28.42% over the past 30 days, MNPR has performed -29.07% over the past quarter and MNPR has shown – over the past 365 days. Monopar Therapeutics Inc. (MNPR) has a 52 week range of $4.77 to $48.00. Monopar Therapeutics Inc. (MNPR) is trading 15.09% from its 52 week low and -88.56% from its 52 week high. Monopar Therapeutics Inc. (MNPR) is displaying a 1.00% short float displaying the amount short in the float.

MNPR has 10.65M shares outstanding and 2.32M shares in the float. Monopar Therapeutics Inc. (MNPR) currently has a market cap of $56.05M and income of -4.50M. The EPS next quarter for MNPR is -0.15 and forecasted EPS next year is -106.00%. The market cap of Monopar Therapeutics Inc. (MNPR) at $56.05M represents how many Traders own shares of MNPR and is calculated off the last price ($5.49) of MNPR and the amount of shares outstanding (10.65M) with Monopar Therapeutics Inc. (MNPR).

Monopar Therapeutics Inc. (MNPR) has total cash (mrq) of 12.55M, total cash per share (mrq) of 1.17, total debt of MNPR remains at 122.4k and total debt/equity (mrq) is 1.01. . Monopar Therapeutics Inc. (MNPR) running cash flow (ttm) is -3.4M, MNPR leveraged free cash flow (ttm) is -1.29M.

MNPR is trading -5.46% below (bearish) its SMA20, -20.07% below (bearish) its SMA50 and -43.50% below (bearish) its SMA200.